UNSPSC 51283701: Cefaclor

This classification denotes a cephalosporin antibiotic with the molecular formula C15H14ClN3O4S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 69K7K19H4L, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6r-(6-alpha,7-beta(r*)))- but generally known as cefaclor, which bears US NIH Compound Identifier 40958. Cefaclor most often comes in base, anhydrous, and hydrate forms.

UNSPSC 51283701 Cefaclor (Commodity) covers pharmaceutical products — in this case, a specific antibiotic — but recent state and local solicitations tagged under this code actually span a much broader range of medical supplies, pharmaceuticals, and health-related products including naloxone, over-the-counter medications, emergency medical supplies, and prescription-fulfillment systems. The divergence between the code's nominal scope and actual procurement signals that state and local buyers are using this code as a catch-all for pharmaceutical and related medical acquisitions rather than strictly for cefaclor itself. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The mix reflects both direct procurement by single jurisdictions and coordinated purchasing through state-sponsored cooperative vehicles that bundle demand across multiple states and local participants.

Activity concentrates in Florida, Texas, and Minnesota based on recent postings. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (IFB60459723LAS, due July 26, 2026, seeking 1,900 units of naloxone and 800 deactivation units annually); the City of Tampa's sealed-bid solicitation for medical and first aid supplies for its Fire Department Rescue Division (26P00145, estimated value $700,000, designated as sheltered for certified Small Local Business Enterprises); MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026, serving multiple state and local facilities including Oregon); and the Texas HHS Commission's Request for Information on a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program (HHS0017013, posted April 3, 2026). The breadth of issuing bodies and the prevalence of cooperative purchasing vehicles suggest that demand under this code flows through both traditional competitive sealed-bid processes and multi-jurisdictional framework agreements.